Spencer Fane is pleased to be a Gold Partner for the IP Litigation North America Summit on September 14-16 in Boston. Attorneys Jeremy Lowe and Brett Pinkus will speak at the conference.
This comprehensive event will convene senior intellectual property corporate counsel, litigators, and other industry stakeholders across three areas of discussion: pharma and biotech, tech and innovation, and trade secrets. As part of the Summit’s pharma and biotech programming, the Spencer Fane team will explore litigation strategies for the current life sciences IP ecosystem. Jeremy will co-lead the Cross-Sector Presentation: Doctrine of Equivalents Review session while Brett will join the Trade Secrets in the Age of AI: How Generative and Agentic Systems are Changing Insider Risk presentation.
Jeremy and Brett are patent litigators who help life sciences clients protect, enforce, and defend critical intellectual property in high-stakes disputes. Their work is supported by the broader Spencer Fane Life Sciences platform, including FDA regulatory, technical, and litigation experience across pharmaceuticals, biologics, medical devices, and related technologies. Jeremy leads the firm’s Patent Litigation and Hatch-Waxman & Biologics teams, and Brett leads the firm’s Medtech and Medical Device team.
Learn more about IP Litigation North America here.